Colby, Donn J.
Sarnecki, Michal http://orcid.org/0000-0001-7035-0020
Barouch, Dan H.
Tipsuk, Somporn
Stieh, Daniel J.
Kroon, Eugène
Schuetz, Alexandra
Intasan, Jintana
Sacdalan, Carlo
Pinyakorn, Suteeraporn
Grandin, Pornsuk
Song, Hongshuo
Tovanabutra, Sodsai
Shubin, Zhanna
Kim, Dohoon http://orcid.org/0000-0002-5794-6222
Paquin-Proulx, Dominic http://orcid.org/0000-0003-1407-3414
Eller, Michael A. http://orcid.org/0000-0003-3905-4877
Thomas, Rasmi http://orcid.org/0000-0002-2116-2418
de Souza, Mark
Wieczorek, Lindsay
Polonis, Victoria R.
Pagliuzza, Amélie
Chomont, Nicolas http://orcid.org/0000-0001-9747-5018
Peter, Lauren
Nkolola, Joseph P.
Vingerhoets, Johan
Truyers, Carla
Pau, Maria G.
Schuitemaker, Hanneke
Phanuphak, Nittaya
Michael, Nelson
Robb, Merlin L. http://orcid.org/0000-0003-3949-9649
Tomaka, Frank L.
Ananworanich, Jintanat
Funding for this research was provided by:
Henry M. Jackson Foundation (W81XWH-07-2-0067)
United States Department of Defense | Biometrics Identity Management Agency (W81XWH-07-2-0067)
Article History
Received: 6 May 2019
Accepted: 24 January 2020
First Online: 23 March 2020
Competing interests
: J.A. has received an honorarium for participation in advisory committees from ViiV Healthcare, Merck, Gilead, AbbVie and Roche. J.A., D.H.B., N.M., M.G.P., M.L.R., H. Schuitemaker and F.L.T. are co-inventors on patents (US application no. 15/693,650, granted as US patent no. 10,307,477; US application no. 16/385,062, granted as US patent no. 10,525,123; international application no. PCT/US2017/049817, pending in Australia, Canada, China, Europe, Japan and South Africa), which have relevance to the vaccine regimen used for the target population in this manuscript. Patent applicants include Janssen Vaccines & Prevention BV, Beth Israel Deaconess Medical Center, Henry M. Jackson Foundation for the Advancement of Military Medicine and The United States of America (represented by the Secretary of the Army). M.S., D.J.S., J.V., C.T., M.G.P., H. Schuitemaker and F.T. are employees of Janssen (Pharmaceutical Companies of Johnson & Johnson) and may be stockholders. All other authors declare no competing interests.